ARK Genomic Revolution ETF (ARKG)

genomics biotechnology active-management

ARKG provides exposure to companies involved in the genomics revolution, including those in gene editing, bioinformatics, and molecular diagnostics. The fund's active management approach allows for flexibility in selecting companies at the forefront of genetic research and innovation. For investors interested in the potential of genomics to transform healthcare, ARKG offers a focused way to access this cutting-edge field.